StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
25
This month
1
This year
5
Publishing Date
2024 - 04 - 11
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 06
1
2024 - 01 - 08
1
2023 - 12 - 08
1
2023 - 10 - 31
1
2023 - 10 - 13
1
2023 - 08 - 07
1
2023 - 07 - 31
1
2023 - 07 - 24
1
2023 - 07 - 05
1
2023 - 06 - 15
1
2023 - 01 - 09
1
2022 - 09 - 20
1
2022 - 09 - 05
1
2022 - 08 - 22
1
2022 - 06 - 20
1
2022 - 05 - 23
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2021 - 11 - 02
1
Sector
Health services
1
Health technology
25
Information
1
Manufacturing
25
Professional, scientific, and technical services
2
Tags
Bladder
1
Blood
1
Cancer
6
Car-t
1
Cell
1
Companies
4
Cue
1
Diagnostics
1
Disease
1
Drug
2
Earnings
1
Expansion
1
Expected
1
Fibromyalgia
1
Global
3
Growing
1
Growth
8
Liver
1
Lung
1
Management
1
Market
18
Melanoma
1
N/a
24
Order
1
Pancreatic
1
Plus
1
Potential
1
Psoriasis
1
Reach
2
Report
5
Research
4
Results
1
Study
1
Therapeutics
5
Therapy
2
Treatment
3
Entities
4d molecular therapeutics inc
2
Abbott laboratories
21
Abbvie inc.
49
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
7
Advaxis, inc.
2
Affimed n.v.
2
Alnylam pharmaceuticals, inc.
2
Amgen inc.
31
Aptevo therapeutics inc.
2
Arvinas, inc.
2
Astellas pharma inc
333
Astrazeneca plc
42
Bausch health companies inc.
6
Baxter international inc.
4
Biogen inc.
11
Biontech se
5
Blackrock, inc.
2
Boston scientific corporation
2
Brainstorm cell therapeutics inc.
5
Bristol-myers squibb company
11
Calliditas therapeutics ab
2
Celyad oncology sa
4
Csl ltd
12
Cti biopharma corp.
2
Cyclacel pharmaceuticals, inc.
2
Eli lilly and company
25
Endo international plc
4
Essa pharma inc.
4
F-star therapeutics inc.
2
Fibrogen, inc
3
Galectin therapeutics inc.
2
Galmed pharmaceuticals ltd.
2
Generation bio co.
6
Gilead sciences, inc.
3
Glaxosmithkline plc
48
Incyte corporation
6
Ionis pharmaceuticals, inc.
3
Ironwood pharmaceuticals, inc.
2
Iveric bio, inc.
10
Jazz pharmaceuticals plc
4
Johnson & johnson
26
Mallinckrodt plc
7
Medtronic plc
3
Merck & company, inc.
4
Mesoblast ltd
6
Mitsubishi chemical holdings corp
3
Novartis ag
70
Novo nordisk a/s
3
Orange
3
Orchard therapeutics plc
7
Pfizer, inc.
26
Sanofi
70
Seagen inc.
20
Takeda pharmaceutical company limited
13
Teva pharmaceutical industries ltd
27
Thermo fisher scientific inc
4
Twist bioscience corporation
3
Ucb s.a.
4
Viatris inc.
22
Symbols
ABBV
111
ABCL
12
ABT
56
ACIU
35
ADCT
13
AKUS
11
ALNY
38
ALPMF
25
ALPMY
25
AMGN
88
AVEO
25
AZN
98
AZNCF
81
BAX
14
BCRX
13
BDX
21
BGNE
19
BIIB
20
BMY
106
BNTX
14
BPMC
20
CLVS
20
DTIL
11
EPZM
20
EXEL
13
GILD
35
GLAXF
80
GSK
107
HCM
11
ILMN
15
INCY
207
JNJ
175
KPTI
20
LLY
1710
MDT
14
MRUS
21
NVO
83
NVS
138
NVSEF
121
OMER
15
OTIC
13
PFE
80
PODD
14
PRQR
18
REGN
36
RIGL
41
SNY
335
SNYNF
253
TAK
42
TEVJF
61
TMO
14
TRUMF
14
TRUMY
14
UCBJF
11
UCBJY
11
UTHR
14
VERU
57
VRTX
12
VTRS
18
YMAB
18
Exchanges
Nasdaq
25
Nyse
25
Crawled Date
2024 - 04 - 11
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 07
1
2024 - 01 - 08
1
2023 - 12 - 08
1
2023 - 10 - 31
1
2023 - 10 - 13
1
2023 - 08 - 07
1
2023 - 07 - 31
1
2023 - 07 - 24
1
2023 - 07 - 05
1
2023 - 06 - 15
1
2023 - 01 - 09
1
2022 - 09 - 20
1
2022 - 09 - 05
1
2022 - 08 - 22
1
2022 - 06 - 20
1
2022 - 05 - 23
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 02 - 22
1
2022 - 02 - 18
1
2021 - 11 - 02
1
Crawled Time
00:00
1
01:00
1
08:00
2
09:00
1
11:00
1
13:00
1
13:30
1
14:00
2
15:00
1
15:20
1
16:00
4
19:00
2
21:00
5
22:00
1
23:00
1
Source
www.biospace.com
1
www.prnewswire.com
24
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Eli lilly and company
symbols :
Alpmf
save search
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published:
2024-04-11
(Crawled : 22:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-5.8%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-7.39%
|
O:
-8.65%
H:
3.19%
C:
1.6%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-1.05%
|
O:
-1.65%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
-3.72%
|
O:
-0.0%
H:
0.52%
C:
-1.04%
growth
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
-5.41%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
9.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
-6.69%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
0.61%
-4.38%
6.1K
|
Manufacturing
|
27.56%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-14.3%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.36
0.91%
0.0%
1.5M
|
Health Technology
|
-9.36%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-7.6%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
-3.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
-1.95%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-3.48%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
-4.79%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-1.81%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
7.74%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
-4.07%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
-1.11%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
14.97%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.36
0.91%
0.0%
1.5M
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-5.73%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
-1.17%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
-0.8%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.99
6.54%
6.01%
460K
|
Health Technology
|
-17.68%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$399.92
1.43%
1.45%
1.1M
|
Health Technology
|
-5.01%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-0.62%
-7.02%
9.5K
|
Health Technology
|
-6.2%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.11
-0.14%
-0.15%
930K
|
Health Technology
|
-20.69%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
14.2%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$368.75
2.37%
2.38%
310K
|
Health Technology
|
-6.1%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
-7.65%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-12.32%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
3.65%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
-7.55%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
0.61%
-4.38%
6.1K
|
Manufacturing
|
38.86%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-12.49%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.36
0.91%
0.0%
1.5M
|
Health Technology
|
-5.65%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-8.65%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-4.25%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
3.73%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-0.24%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
-1.83%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$399.92
1.43%
1.45%
1.1M
|
Health Technology
|
-4.46%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-0.55%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$108.83
-1.01%
-1.04%
510K
|
Health Technology
|
-12.73%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
4.61%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
-13.97%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published:
2024-01-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-21.72%
|
O:
-0.85%
H:
1.05%
C:
0.08%
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-8.67%
|
O:
2.07%
H:
0.48%
C:
0.48%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-21.63%
|
O:
0.53%
H:
3.97%
C:
0.45%
CLVT
|
$7.15
2.29%
1.82%
5.8M
|
Information
|
-17.53%
|
O:
0.92%
H:
6.4%
C:
5.03%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-7.08%
|
O:
0.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
18.23%
|
O:
0.63%
H:
0.58%
C:
0.58%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-9.16%
|
O:
1.16%
H:
0.0%
C:
0.0%
CALT
|
$18.0825
-3.3%
-1.71%
2
|
Health Technology
|
-23.85%
|
O:
2.68%
H:
3.22%
C:
0.35%
report
potential
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
-1.82%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-22.27%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.36
0.91%
0.0%
1.5M
|
Health Technology
|
-5.11%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$125.26
2.08%
0.98%
3.5M
|
Health Technology
|
29.39%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-1.21%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-4.39%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
24.67%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-2.03%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
13.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
1.21%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.95
0.29%
0.28%
3.8M
|
Health Technology
|
-14.22%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
0.22%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
Primary Sclerosing Cholangitis Market to Grow at a Tremendous CAGR of 17.2% During the Study Period (2019-2032) | DelveInsight
Published:
2023-10-31
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
3.73%
|
O:
0.94%
H:
2.55%
C:
2.55%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-24.9%
|
O:
-4.18%
H:
0.49%
C:
-0.02%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
28.69%
|
O:
-2.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
1.57%
|
O:
0.18%
H:
0.0%
C:
0.0%
PLRX
|
$12.6
0.64%
0.71%
210K
|
Health Technology
|
-14.11%
|
O:
-0.2%
H:
3.45%
C:
1.37%
CALT
|
$18.0825
-3.3%
-1.71%
2
|
Health Technology
|
10.92%
|
O:
-2.27%
H:
2.01%
C:
0.44%
study
market
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published:
2023-10-13
(Crawled : 16:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-26.96%
|
O:
-1.86%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-29.36%
|
O:
-2.78%
H:
0.04%
C:
-0.57%
VTRS
|
News
A
|
$11.25
-0.13%
4.1M
|
Health Technology
|
18.92%
|
O:
-0.21%
H:
0.42%
C:
-1.17%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-3.17%
|
O:
-0.55%
H:
0.69%
C:
-0.09%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-4.25%
|
O:
0.64%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
20.18%
|
O:
1.15%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
13.21%
|
O:
0.38%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
2.97%
|
O:
-0.59%
H:
0.62%
C:
-0.56%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
-4.61%
|
O:
0.93%
H:
0.26%
C:
-1.25%
management
growing
Bladder Cancer Market Likely to Exhibit Substantial Growth, Assesses DelveInsight | Leading Companies - CicloMed, Bristol-Myers Squibb, CG Oncology, Merck, Eli Lilly and Company, UroGen, Ferring
Published:
2023-08-07
(Crawled : 21:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-38.12%
|
O:
0.19%
H:
0.0%
C:
-2.72%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
61.06%
|
O:
11.43%
H:
6.32%
C:
3.08%
URGN
|
$14.37
4.66%
4.45%
280K
|
Health Technology
|
-28.15%
|
O:
-1.3%
H:
6.76%
C:
5.57%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-18.4%
|
O:
2.58%
H:
0.41%
C:
-1.13%
FUSN
|
$21.32
0.28%
0.3%
340K
|
Health Technology
|
605.96%
|
O:
10.6%
H:
0.0%
C:
-9.58%
companies
bladder
cancer
market
Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte
Published:
2023-07-31
(Crawled : 09:00)
- prnewswire.com
TYRA
|
$15.5
3.47%
3.48%
68K
|
Health Technology
|
8.01%
|
O:
-0.42%
H:
8.05%
C:
3.71%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-35.82%
|
O:
0.34%
H:
1.07%
C:
-1.81%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
59.51%
|
O:
-0.44%
H:
0.0%
C:
0.0%
URGN
|
$14.37
4.66%
4.45%
280K
|
Health Technology
|
-36.44%
|
O:
-1.59%
H:
0.94%
C:
-2.65%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-10.83%
|
O:
3.56%
H:
0.0%
C:
0.0%
NKTR
|
News
|
$1.36
9.68%
9.49%
1.9M
|
Health Technology
|
149.54%
|
O:
-0.73%
H:
4.99%
C:
-0.96%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-17.7%
|
O:
-0.03%
H:
1.4%
C:
1.03%
ARAV
|
$0.0401
4.74%
4M
|
Health Technology
|
-96.72%
|
O:
6.38%
H:
0.33%
C:
-6.67%
ADXS
|
$0.572
12.48%
270
|
Health Technology
|
-51.28%
|
O:
-1.71%
H:
3.48%
C:
-5.43%
companies
expected
growth
market
Cutaneous Melanoma Market is Predicted to Exhibit Remarkable Growth, Predicts DelveInsight | Key Companies - Merck, Amgen, Anaveon, Eisai, Regeneron, BMS, AstraZeneca, Seagen, Novartis, Eli Lilly and Company
Published:
2023-07-24
(Crawled : 21:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-35.56%
|
O:
-0.61%
H:
0.14%
C:
0.14%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
59.22%
|
O:
-0.34%
H:
0.69%
C:
-0.05%
GALT
|
$3.06
-9.2%
-10.31%
310K
|
Health Technology
|
92.45%
|
O:
-1.57%
H:
4.79%
C:
0.32%
melanoma
companies
market
Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight
Published:
2023-07-05
(Crawled : 21:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-33.32%
|
O:
0.86%
H:
0.0%
C:
-1.01%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-4.22%
|
O:
-1.17%
H:
0.63%
C:
0.22%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
57.04%
|
O:
-0.55%
H:
0.97%
C:
0.02%
VERU
|
$1.27
-3.05%
-3.15%
1.3M
|
Health Technology
|
5.83%
|
O:
-0.83%
H:
0.0%
C:
-6.72%
OPK
|
$1.23
0.0%
1.9M
|
Health Technology
|
-41.43%
|
O:
-1.19%
H:
1.2%
C:
-0.72%
ADXS
|
$0.572
12.48%
270
|
Health Technology
|
-40.0%
|
O:
0.0%
H:
0.0%
C:
-6.83%
cancer
global
growth
market
Metastatic Pancreatic Cancer Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - FibroGen, AstraZeneca, Jiangsu HengRui, ImmunityBio, SynerGene, Mirati, Incyte, Astellas, AbbVie, Cue Biopharma, PureTech
Published:
2023-06-15
(Crawled : 15:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-41.64%
|
O:
-0.92%
H:
0.0%
C:
-0.37%
BMEA
|
$10.83
-0.18%
0.09%
490K
|
Professional, Scientific, and T...
|
-72.16%
|
O:
-0.15%
H:
0.0%
C:
-5.2%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
63.35%
|
O:
0.06%
H:
1.91%
C:
1.32%
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
-15.49%
|
O:
-0.11%
H:
2.08%
C:
1.97%
companies
cue
cancer
pancreatic
market
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published:
2023-01-09
(Crawled : 16:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-31.34%
|
O:
3.03%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
26.8%
|
O:
3.12%
H:
0.0%
C:
-2.55%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-34.64%
|
O:
0.58%
H:
0.44%
C:
-0.31%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
2.69%
|
O:
0.76%
H:
0.26%
C:
-3.27%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
101.5%
|
O:
0.29%
H:
0.27%
C:
-3.89%
BMY
|
$49.14
0.43%
0.2%
6.4M
|
Health Technology
|
-32.68%
|
O:
0.16%
H:
0.05%
C:
-2.89%
BNTX
|
News
|
$88.01
1.38%
1.36%
240
|
Health Technology
|
-41.36%
|
O:
1.42%
H:
0.64%
C:
-2.27%
research
car-t
therapy
market
Bipolar Disorder Therapeutics Global Market to Reach $7.67 Billion by 2026
Published:
2022-09-20
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
41.86%
|
O:
3.21%
H:
0.07%
C:
-5.89%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
25.54%
|
O:
0.05%
H:
4.96%
C:
0.66%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
47.0%
|
O:
0.98%
H:
0.0%
C:
-1.99%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-30.13%
|
O:
-1.47%
H:
0.74%
C:
-0.3%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
19.09%
|
O:
-0.73%
H:
0.04%
C:
-1.85%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
33.13%
|
O:
-0.49%
H:
0.07%
C:
-1.88%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
142.38%
|
O:
-0.24%
H:
1.17%
C:
-1.5%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
18.42%
|
O:
0.27%
H:
1.04%
C:
-1.29%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
22.18%
|
O:
-0.1%
H:
0.14%
C:
-1.57%
global
therapeutics
market
Vitiligo Treatment Market Size Worth US$ 2.42 Billion With CAGR of 6.14% from 2022 to 2030 | Exclusive Report by Growth Plus Reports
Published:
2022-09-05
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$51.92
-0.82%
-0.83%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
treatment
report
plus
growth
market
Global Fibromyalgia Treatment Market to Surpass US$ 4,079.0 Million by 2030 - Coherent Market Insights
Published:
2022-08-22
(Crawled : 19:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-35.09%
|
O:
-0.56%
H:
0.62%
C:
-0.82%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-46.3%
|
O:
-0.98%
H:
0.21%
C:
-0.85%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
12.3%
|
O:
-0.91%
H:
0.1%
C:
-0.17%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
126.35%
|
O:
-0.58%
H:
0.19%
C:
-1.91%
treatment
global
fibromyalgia
market
Insights on the Psoriasis Therapeutics Global Market to 2028 - Cumulative Development of New Biologics and New Pipeline Drugs Presents Opportunities
Published:
2022-06-20
(Crawled : 15:20)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
Email alert
Add to watchlist
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
psoriasis
market
drug
Global $3.12 Billion Head and Neck Cancer Therapeutics Markets, Analysis, Opportunities and Forecasts, 2027
Published:
2022-05-23
(Crawled : 11:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-17.6%
|
O:
-3.11%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
9.18%
|
O:
5.07%
H:
0.28%
C:
-1.81%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-37.65%
|
O:
1.8%
H:
0.26%
C:
-0.13%
TEVA
|
$12.88
0.16%
-0.08%
7.9M
|
Health Technology
|
51.89%
|
O:
0.94%
H:
0.93%
C:
-1.29%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
153.07%
|
O:
3.76%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.89
0.89%
0.51%
3.6M
|
Health Technology
|
10.13%
|
O:
-0.51%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-14.45%
|
O:
1.61%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
7.22%
|
O:
1.61%
H:
1.29%
C:
-0.08%
therapeutics
cancer
Global Genitourinary Drugs Market Research Report to 2027 - Increasing Prevalence of Genitourinary Disorders is Driving Growth
Published:
2022-04-26
(Crawled : 14:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
6.33%
43.47%
52
|
Health Technology
|
-36.73%
|
O:
2.56%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-39.95%
|
O:
0.13%
H:
0.06%
C:
-0.69%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-45.08%
|
O:
3.08%
H:
0.0%
C:
0.0%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
5.49%
|
O:
0.47%
H:
0.83%
C:
-1.44%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-18.34%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.36%
1.7M
|
Health Technology
|
156.43%
|
O:
0.34%
H:
1.41%
C:
-1.17%
IONS
|
$41.07
0.96%
0.97%
710K
|
Health Technology
|
-3.0%
|
O:
-0.12%
H:
0.07%
C:
-5.13%
research
report
growth
market
drug
← Previous
1
2
Next →
Gainers vs Losers
73%
27%
Top 10 Gainers
AGBA
|
$2.5
100.0%
58.33%
200M
|
Finance
EDBL
|
News
|
$6.26
66.49%
48.56%
270K
|
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
SILO
|
$1.99
0.71%
20.64%
1.8M
|
Finance and Insurance
DPRO
|
News
|
$0.28
16.91%
16.26%
24K
|
CANG
|
$1.34
-4.29%
14.93%
120K
|
Technology Services
AZTR
4
|
$0.195
13.85%
42K
|
n/a
TOVX
|
News
|
$0.411
-1.01%
12.9%
230K
|
Manufacturing
CISS
|
$1.3
11.11%
10.0%
42K
|
n/a
SQNS
|
$0.504
-9.19%
9.25%
110K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.